The effect of serotonin reuptake inhibitors on hepatic injury induced by carbon tetrachloride

Comparative Clinical Pathology

Volumn 21, Issue 1, 2012, Pages 77-89

  Abdel Salam, Omar M E ^a   Sleem, Amany A ^a   Shafee, Nermeen ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Carbon tetrachloride; Liver; Rat; Serotonin reuptake inhibitors

Indexed keywords

EID: 84856251206     PISSN: 16185641     EISSN: 1618565X     Source Type: Journal    
DOI: 10.1007/s00580-010-1067-5     Document Type: Article

References (61)

1. Abdelmalik N, Ruhé HG, Barwari K, van den Dool E-J, Meijers JCM, Middeldorp S, Buller HR, Schene AH, Kamphuisen PW (2008) Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J Thromb Haemost 6: 2168-2174.
2. Abdel Salam OME, Sleem AA, Shaffie NM (2006) Effect of the selective serotonin reuptake inhibitor fluoxetine on carbon tetrachloride induced hepatic damage in rats. J Pharmacol Toxicol 1: 395-406.
3. Albrecht J, Jones EA (1999) Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci 170(2): 138-146.
4. al_Mardini H, Harrison EJ, Ince PG, Bartlett K, Record CO (1993) Brain indoles in human hepatic encephalopathy. Hepatology 17(6): 1033-1040.
5. An Z, Moore MC, Winnick JJ, Farmer B, Neal DW, Lautz M, Smith M, Rodewald T, Cherrington AD (2009) Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs. Eur J Pharmacol 607(1-3): 251-257.
6. Balasubramanian S, Paulose CS (1998) Induction of DNA synthesis in primary cultures of rat hepatocytes by serotonin: possible involvement of serotonin S2 receptor. Hepatology 27: 62-66.
7. Belfield A, Goldberg DM (1971) Revised assay for serum phenyl phosphatase activity using 4-amino-antipyrine. Enzyme 12: 561-573.
8. Bertrand PP, Hu X, Mach J, Bertrand RL (2008) Serotonin (5-HT) release and uptake measured by real-time electrochemical techniques in the rat ileum. Am J Physiol 295: G1228-G1236.
9. Briscoe VJ, Ertl AC, Tate DB, Davis SN (2008a) Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes. Diabetes 57(12): 3315-3322.
10. Briscoe VJ, Ertl AC, Tate DB, Dawling S, Davis SN (2008b) Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals. Diabetes 57(9): 2453-2460.
11. Cai W, Khaoustov VI, Xie Q, Pan T, Le W, Yoffe B (2005) Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression. J Hepatol 42: 880-887.
12. Carvalho F, Barros D, Silva J, Rezende E, Soares M, Fregoneze J, De Castro e Silva E (2004) Hyperglycemia induced by acute central fluoxetine administration: role of the central CRH system and 5-HT3 receptors. Neuropeptides 38(2-3): 98-105.
13. Crowley LV (1967) The Reitman-Frankel colorimetric transaminase procedure in suspected myocardial infarction. Clin Chem 13: 482-487.
14. Culafic D, Dukic V, Mirkovic D, Karamarkovic A (2004) Hyperdynamic circulation and serotonin levels in patients with liver cirrhosis. Jugoslov Med Biohem 23: 31-35.
15. de Abajo FJ, Rodriguez LA, Montero D (1999) Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. Br Med J 319: 1106-1109.
16. De Clerck F (1990) The role of serotonin in thrombogenesis. Clin Physiol Biochem 8(Suppl 3): 40-49.
17. DeSanty KP, Amabile CM (2007) Antidepressant-induced liver injury. Ann Pharmacother 41(7): 1201-1211.
18. Drury RVA, Walligton EA (1980) Carlton's histological techniques, 5th edn. Oxford University Press, New York, 206.
19. Evangelista S (1994) Role of calcitonin gene-related peptide in gastric mucosal defence. Gastroprotection I: 10-14.
20. Flechtner-Mors M, Jenkinson CP, Alt A, Adler G, Ditschuneit HH (2008) Metabolism in adipose tissue in response to citalopram and trimipramine treatment-an in situ microdialysis study. J Psychiatr Res 42(7): 578-586.
21. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975-982.
22. Gershon MD, Tack J (2007) The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132: 397-414.
23. Gleason OC, Yates WR, Isbell MD, Philipsen MA (2002) An open-label trial of citalopram for major depression in patients with hepatitis C. J Clin Psychiatry 63(3): 194-198.
24. Gibbons SS (2000) Antidepressants. In: Edmunds MW, Mayhew MS (eds) Pharmacology for the primary care provider. Mosby Inc, St. Louis, Missouri, USA, pp 602-620.
25. Goodnick PJ, Goldstein BJ (1998) Selective serotonin reuptake inhibitors in affective disorders. Basic pharmacology. J Psychopharmacol 12(suppl B): S5-S20.
26. Hainer V, Kabrnova K, Aldhoon B, Kunesova M, Wagenknecht M (2006) Serotonin and norepinephrine reuptake inhibition and eating behavior. Ann N Y Acad Sci 1083: 252-269.
27. Holzer P, Lippe I, Raybould HE, Pabst MA, Livingston EH, Amann R, Peskar BM, Peskar BA, Taché Y, Guth PH (1991) Role of peptidergic sensory neurons in gastric mucosal blood flow and protection. Ann NY Acad Sci 632: 272-282.
28. Jones EA (2001) Altered central serotoninergic neurotransmission: a potential mechanism for profound fatigue complicating chronic hepatitis C. Med Hypotheses 57: 133-134.
29. Kitagawa T, Yokoyama Y, Kokuryo T, Kawai T, Watanabe K, Kawai K, Nagino M (2008) Estrogen promotes hepatic regeneration via activating serotonin signal. Shock 31(6): 616-621.
30. Krahenbuhl S, Weber FL Jr, Brass EP (1991) Decreased hepatic glycogen content and accelerated response to starvation in rats with carbon tetrachloride-induced cirrhosis. Hepatology 14(6): 1189-1195.
31. Laffi G, Marra F, Gresele P (1992) Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology 103: 641-646.
32. Lang JP, Meyer N, Doffoel M (2003) Benefits of a preventive psychiatric accompaniment in patients Hepatitis C virus seropositive (HCV): prospective study concerning 39 patients (Article in French). Encephale 29(4 Pt 1): 362-365.
33. Lang PA, Contaldo C, Georgiev P, El-Badry AM, Recher M, Kurrer M, Cervantes-Barragan L, Ludewig B (2008) Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med 14(7): 756-761.
34. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, Gachet C, Bader M, Clavien PA (2006) Platelet-derived serotonin mediates liver regeneration. Science 312(5770): 104-107.
35. Lesurtel M, Soll C, Graf R, Clavien PA (2008) Role of serotonin in the hepato-gastrointestinal tract: an old molecule for new perspectives. Cell Mol Life Sci 65: 940-952.
36. Lozeva V, Montgomery JA, Tuomisto L, Rocheleau B, Pannunzio M, Huet PM, Butterworth RF (2004) Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis. J Hepatol 40(5): 742-774.
37. Mayo MJ, Handem I, Saldana S, Jacobe H, Getachew Y, Rush AJ (2007) Sertraline as a first-line treatment for cholestatic pruritus. Hepatology 45(3): 666-674.
38. Mac-Manus JPA, Cason JE (1950) Carbohydrate histochemistry studies by acetylation technique. Periodic acid method. J Exp Med 91: 651.
39. Marasini B, Biondi ML, Agostoni A (1989) Platelet and plasma serotonin in patients with liver cirrhosis. J Clin Chem Clin Biochem 27(7): 419-421.
40. Maurer-Spurej E, Pittendreigh C, Solomons K (2004) The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost 91(1): 119-128.
41. Mazia D, Drewer PA, Alfert M (1953) The cytochemical staining and measurement of protein with mercaric bromophenol blue. Biol Bull 104: 57-67.
42. McCloskey DJ, Postolache TT, Vittone BJ, Nghiem KL, Monsale JL, Wesley RA, Rick ME (2008) Selective serotonin reuptake inhibitors: measurement of effect on platelet function. Translational Research 151: 168-172.
43. Moore MC, DiCostanzo CA, Dardevet D, Lautz M, Farmer B, Neal DW, Cherrington AD (2004) Portal infusion of a selective serotonin reuptake inhibitor enhances hepatic glucose disposal in conscious dogs. Am J Physiol 287(6): E1057-E1063.
44. Murata R, Hamada N, Nakamura N, Kobayashi A, Fukueda M, Taira A, Sakata R (2003) Serotonin activity and liver dysfunction following hepatic ischemia and reperfusion. In Vivo 17(6): 567-572.
45. Muriel P, Alba N, Perez-Alvarez VM, Shibayama M, Tsutsumi VK (2001) Kupffer cells inhibition prevents hepatic lipid peroxidation and damage induced by carbon tetrachloride. Comp Biochem Physiol C Toxico Pharmacol 130: 219-226.
46. Nelson DL, Gehlert DR (2006) Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine 29(1): 49-60.
47. Nocito A, Georgiev P, Dahm F, Jochum W, Bader M, Graf R, Clavien PA (2007) Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology 45(2): 369-376.
48. Paget GE, Barnes JM (1964) Toxicity testing. In: Laurence DR, Bacharach AL (eds) Evaluation of drug activities pharmacometics. Academic, London, pp 1-135.
49. Reilly FD, Cilento EV, McCuskey RS (1984) Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin. Microcirc Endothelium Lymphatics 1(6): 671-689.
50. Reinshagen M, Mig GNF, Ernst S, Geerling I, Wong H, Walsh JH, Eysselein VE, Adler G (1994) Calcitonin gene-related peptide mediates the protective effect of sensory nerves in a model of colonic injury. Gastroenterology 106: 1208-1212.
51. Sanchez C, Hyttel J (1999) Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 19: 467-489.
52. Sanders NM, Wilkinson CW, Taborsky GJ Jr, Al-Noori S, Daumen W, Zavosh A, Figlewicz DP (2008) The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia. Am J Physiol Endocrinol Metab 294(5): E853-E860.
53. Schafer M, Schmidt F, Amann B, Schlasser S, Loeschke K, Grunze H (2000) Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis. Neuropsychobiology 42(Suppl 1): 43-45.
54. Shimabukuro R, Kawanaka H, Tomikawa M, Akahoshi T, Konishi K, Yoshida D, Anegawa G (2009) Effect of thrombopoietin on platelet counts and liver regeneration after partial hepatectomy in a rat model. Surg Today 39: 1054-1059.
55. Tanaka N, Tanaka K, Nagashima Y, Kondo M, Sekihara H (1999) Nitric oxide increases hepatic arterial blood flow in rats with carbon tetrachloride-induced acute hepatic injury. Gastroenterology 117: 173-180.
56. Tian WN, Braunstein LD, Apse K, Pang J, Rose M, Tian X, Stanton RC (1999) Importance of glucose-6-phosphate dehydrogenase activity in cell death. Am J Physiol 276: C1121-C1131.
57. Ulrich RG, Bacon JA, Brass EP, Cramer CT, Petrella DK, Sun EL (2001) Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon. Chem-Biol Interact 134: 251-270.
58. Vaswani M, Linda FK, Ramesh S (2003) Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27(1): 85-102.
59. Verbeuren TJ (1989) Synthesis, storage, release and metabolism of 5-hydroxytryptamine in peripheral tissues. In: Fozard JR (ed) The peripheral actions of 5-hydroxytryptamine. Oxford University Press, New York, pp 1-25.
60. Wessinger S, Kaplan M, Choi L, Williams M, Lau C, Sharp L, Crowell MD, Keshavarzian A, Jones MP (2006) Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 23(7): 937-944.
61. Zignego AL, Cozzi A, Carpenedo R, Giannini C, Rosselli M, Biagioli T, Aldinucci A, Laffi G, Moroni F (2007) HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment. Dig Liver Dis 39(Suppl 1): S107-S111.